
|Articles|December 10, 2020
Flip the Script
Author(s)Gagen MacDonald
Life sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
How Will MFN’s Effects on Medicare Impact Innovation?
5